期刊文献+

血管内皮生长因子反义核酸对细胞株HL60及耐药细胞株HL60/VCR的抑制作用 被引量:1

Inhibiting Effect of Vascular Endothelial Growth Factor Antisense Oligonucleotides on HL60 Cell and HL60/VCR Multidrug Resistance Cell
下载PDF
导出
摘要 目的探讨反义血管内皮生长因子(AS-VEGF)对HL60、耐药细胞株HL60/VCR的影响及其机制,包括基因水平的耐药相关基因(Bcl-2,Mcl-1,MDR1,MRP,GSTπ,TopoⅡα,TopoⅡβ)和蛋白水平的耐药相关蛋白P糖蛋白(P-gp)表达量变化。方法分子生物学方法构建AS-VEGF表达真核载体,通过脂质体转染技术将其转染至细胞株HL60和耐药细胞株HL60/VCR内,观察并绘制细胞生长曲线,ELISA法检测细胞培养上清VEGF表达量变化,RT-PCR法从mRNA水平检测细胞内耐药相关基因表达,蛋白质印迹方法从蛋白水平检测细胞表面P-gp表达。结果1.25mmol/L的AS-VEGF真核表达载体转染HL60和HL60/VCR细胞株后继续培养24和48h与未转染组比较均可明显抑制细胞生长,细胞生长减慢;转染组细胞48与24h相比较VEGF、MDR1、MRP、GSTπ和TopoⅡβ的表达量均明显减少,Bcl-2、Mcl-1和TopoⅡα表达量则无明显变化;转染组HL60/VCR细胞表面P-gp表达量48与24h相比较也明显减少。结论AS-VEGF可通过抑制白血病细胞生长,改变细胞内的微环境和细胞膜相关蛋白转运通道,降低细胞解毒能力和自我修复能力逆转白血病细胞多药耐药。 Objective To explore the effect of vascular endothelial growth factor antisense oligonucleotides ( AS - VEGF) on HL60 cell and HL60/VCR multidrug resistance cell and analyze the function of P - gp and the expression of related multidrug resistance genes including Bcl - 2, Mcl - 1, MDR1, MRP, GSTπ,Topo Ⅱα and Topo Ⅱβ. Methods A vector AS - VEGF which expressed in eukaryotic cell was established ,then transfected the vector into HL60 and HL60/VCR by lirnposome transfection technology, observed and drew the growth curve by Tapanlan raining, RT - PCR was used to detect the expression of Bcl -2, Mcl - 1, MDR1, MRP, GSTπ, Topo Ⅱ α and Topo Ⅱβ in mRNA level after transfected 24 h and 48 h. Western Blot was used to detect the expression of P - gp in proteinum level after transfected 24 h and 48 h. Results The growth of HL60 and HL60/VCR was inhibited by AS - VEGF( 1.25 mmol/L). Between HL60 and HL60/VCR, AS - VEGF decreased the expression of MDRI, MRP, GSTπ and Topo I113 but could not influence the expression of Bcl - 2, Mcl - 1 and Topo Ⅱα, and the expression of P - gp was also obviously decreased in 48 h compared with that in 24 h. Conclusions AS - VEGF can inhibite the growth of HL60 and HL60/VCR and reverse multidrug resistance by changing cell microenvironment and the cell membrane correlated protein transportaring channel, reduce the cell disintoxicating and the self - repair ability.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第9期689-691,697,共4页 Journal of Applied Clinical Pediatrics
基金 广东省科技攻关项目资助(2006B36301003)
关键词 血管内皮生长因子 多药耐药 HL60 HL60/VCR vascular endothelial growth factor multidrug resistance HL60 HL60/VC R
  • 相关文献

参考文献1

二级参考文献13

  • 1李莉,谢晓恬,梁爱斌,廖雪莲,石苇,杨莉莉,陈凤翠.血管内皮生长因子在急性白血病细胞株的表达[J].中国小儿血液,2004,9(4):170-174. 被引量:6
  • 2Tisscher E,Cospdarowicz D,Mitchll R,Silva M,Schilling J,Lau K,et al.Vaseular endothelial growth factors:a new member of the palatelet-derived growth factor gene family[J].Biochcm Biophy Res Commun,1989,165(3):1198-1206.
  • 3Bellamy WT,Richter L,Frutiger Y,Grogan TM.Expression of vascular endothelial growth factor and its receptor in hematopoietic malignancies[J].Cancer Res,1999,59(3):728-733.
  • 4Hussong JW,Rodgers GM,Shami PJ.Evidence of increased angiogenesis in patients with acute mycloid leukemia[J].Blood,2000,95 (1):309-313.
  • 5Aguayo A,Kantarjian H,Manshouri T,Gidel C,Estey E,Thomas D,et al.Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes[J].Blood,2000,96(6):2240-2245.
  • 6Katoh O,Takahashi T,Oguri T,Kuramoto K,Mihara K,Kobayashi M,et al.Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by indducing MCL1 acting as an antiapoptotic factor[J].Cancer Rcs,1998,58(23):5565-5569.
  • 7Padro T,Ruiz S,Bieker R,Burger H,Steins M,Kienast J,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia[J].Blood,2000,95(8):2637-2644.
  • 8Aguayo A,Kantarjian HM,Estey EH,Giles FJ,Verstovsek S,Manshouri T,et al.Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes[J].Cancer,2002,95(9):1923-1930.
  • 9Bellamy WT,Richter L,Frutiger Y,Grogan TM.Expression of vascular endothelial growth factor and its receptor in hematopoietic malignancies[J].Cancer Rcs,1999,59 (1):728-733.
  • 10Veikkola T,Karkkainen M,Claesson-Welsh L,Alitalo K.Regulation of angiogencsis via vascular endothelial growth factor receptors[J].Cancer Res,2000,15,60(2):203-212.

共引文献2

同被引文献20

  • 1沈慧玲,许文林,吴朝阳,契燕燕,钟锡明,黄卫兵,肖明.应用RNA干扰技术抑制白血病细胞血管内皮生长因子基因表达及功能的研究[J].中华血液学杂志,2005,26(12):710-714. 被引量:1
  • 2Li WW, Hutnik M, Gehr G. Antiangiogenesis in haematological malignancies [ J ]. Br J Haernatol,2008,143 (5) :622 - 631.
  • 3Barbarroja N,Velasco F. Intracellular mechanisms involved in the angiogenic process in hematological malignancies [ J ]. Med Clin ( Barc ), 2008,130 ( 15 ) :585 - 590.
  • 4Lyu C J, Rha SY, Won SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia[ J]. Yonsei Med J,2007,48 (2) : 171 - 175.
  • 5Fragoso R, Pereira T, Wu Y, et al. VEGFR - 1 ( FLT - 1 ) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease [ J ]. Blood ,2006,107 (4) :1608 - 1616.
  • 6Santos SC, Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways[ J]. Blood,2004,103 ( 10 ) :3883 - 3889.
  • 7Dias S, Hattori K, Zhu Z ,et al. Autocrine stimulation of VEGFR -2 activates human leukemic cell growth and migration [ J ]. J Clin lnvest, 2000,106(4) :511 -521.
  • 8Wegiel B,Ekberg J,Talasila KM,et al. The role of VEGF and a functional link between VEGF and p27 ( Kip1) in acute myeloid leukemia [ J]. Leukemia ,2009,23 (2) :251 - 261.
  • 9Hou HA, Chou WC, Lin LI, et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia[ J ]. Leuk Res,2008,32 (6) :904 - 912.
  • 10Madry K, Dwilewicz - Trojaczek J, Suleiman W, et al. Angiogenesis in bone marrow of myelodysplastic syndrome patients [ J ]. Pol Arch Med Wewn,2007,117(4) :25 -30.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部